Skip to main content

Advertisement

Log in

Specific Features of Transcription Activity of Cancer-Testis Antigens in Patients with Metastatic and Non-Metastatic Breast Cancer

  • ONCOLOGY
  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

Cancer-testis antigens, effective markers of tissue malignant transformation, are characterized by heterogonous transcription depending on the pathological features of breast cancer. We performed screening of transcription profile of cancer-testis antigens specific for breast tumor tissues in female patients with and without regional metastasis. The relative expression of 16 genes (MAGEA1, MAGEA2, MAGEA3, MAGEA4, MAGEB1, MAGEB2, GAGE1, GAGE3, GAGE4, MAGEC1, BAGE, XAGE3, NY-ESO1, SSX2, SYCP1, and PRAME1) was analyzed by RT-qPCR method in biopsy specimens of the mammary gland tissues obtained during surgery from 25 patients. Differential transcription activity of cancer-testis antigens genes was observed in patients with metastatic (enhanced expression of MAGEA2, MAGEB1, and XAGE3 genes) and non-metastatic (enhanced expression of GAGE3 and PRAME1 genes) breast cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Vodolazhsky DI, Kutilin DS, Mogushkova KA, Vashchenko LN, Nikitina VP, Kit OI. Transcriptional activity of cancer-testis antigens in patients with breast cancer of luminal subtypes A and B. Sovremen. Probl. Nauki Obrazovaniya. 2017;(4):5. Russian.

  2. Kutilin DS, Dimitriadi SN, Vodolazhsky DI, Frantsiyants HM, Kit OI. Effect of thermal ischemia-reperfusion on expression of apoptosis-regulating genes in the renal tissue of patients with renal cell carcinoma. Nefrologiya. 2017;21(1):80-86. Russian.

    Google Scholar 

  3. Pak DD, Usov FN, Fetisova EYu, Volchenko AA, Efanov VV. Modern approaches to the treatment of patients with in situ breast carcinoma. Onkologiya. 2013;1(4):30-33. Russian.

    Google Scholar 

  4. Przhedetskii YuV, Vodolazhsky DI, Shatova Yu, Komova EA, Dvadnenko KV. BRCA mutations in patients with clinical signs of hereditary breast cancer in the Southern Federal district. Zlokach. Opukholi. 2015;(S2):196-197. Russian.

  5. Ahmad A. Pathways to breast cancer recurrence. ISRN Oncol. 2013;2013. ID 290568. doi: https://doi.org/10.1155/2013/290568.

  6. Aoki M, Ueda S, Nishikawa H, Kitano S, Hirayama M, Ikeda H, Toyoda H, Tanaka K, Kanai M, Takabayashi A, Imai H, Shiraishi T, Sato E, Wada H, Nakayama E, Takei Y, Katayama N, Shiku H, Kageyama S. Antibody responses against NY-ESO-1 and HER2 antigens in patients vaccinated with combinations of cholesteryl pullulan (CHP)-NY-ESO-1 and CHP-HER2 with OK-432. Vaccine. 2009;27(49):6854-6861.

    Article  PubMed  CAS  Google Scholar 

  7. Chomczynski P, Sacchi N. The single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction: twenty-something years on. Nat. Protoc. 2006;1(2):581-585.

    Article  PubMed  CAS  Google Scholar 

  8. Grigoriadis A, Caballero OL, Hoek KS, da Silva L, Chen YT, Shin SJ, Jungbluth AA, Miller LD, Clouston D, Cebon J, Old LJ, Lakhani SR, Simpson AJ, Neville AM. CT-X antigen expression in human breast cancer. Proc. Natl Acad. Sci. USA. 2009;106(32):13,493-13,498.

    Article  Google Scholar 

  9. Kavalar R, Sarcevic B, Spagnoli G.C, Separovic V, Samija M, Terracciano L, Heberer M, Juretic A. Expression of MAGE tumour-associated antigens is inversely correlated with tumour differentiation in invasive ductal breast cancers: an immunohistochemical study. Virchows Arch. 2001;439(2):127-131.

    Article  PubMed  CAS  Google Scholar 

  10. Krüger S, Ola V, Feller A.C, Fischer D, Friedrich M. Expression of cancer-testis antigen CT7 (MAGE-C1) in breast cancer: an immunohistochemical study with emphasis on prognostic utility. Pathol. Oncol. Res. 2007;13(2):91-96.

    Article  PubMed  Google Scholar 

  11. Lian Y, Sang M, Ding C, Zhou X, Fan X, Xu Y, Lü W, Shan B. Expressions of MAGE-A10 and MAGE-A11 in breast cancers and their prognostic significance: a retrospective clinical study. J. Cancer Res. Clin. Oncol. 2012;138(3):519-527.

    Article  PubMed  CAS  Google Scholar 

  12. Matković B, Juretić A, Spagnoli G.C, Separović V, Gamulin M, Separović R, Sarić N, Basić-Koretić M, Novosel I, Kruslin B. Expression of MAGE-A and NY-ESO-1 cancer/testis antigens in medullary breast cancer: retrospective immunohistochemical study. Croat. Med. J. 2011;52(2):171-177.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 2008;3(6):1101-1108.

    Article  PubMed  CAS  Google Scholar 

  14. Theurillat JP, Ingold F, Frei C, Zippelius A, Varga Z, Seifert B, Chen YT, Jäger D, Knuth A, Moch H. NY-ESO-1 protein expression in primary breast carcinoma and metastases: correlation with CD8+ T-cell and CD79a+ plasmacytic/B-cell infiltration. Int. J. Cancer. 2007;120(11):2411-2417.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to D. S. Kutilin.

Additional information

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 165, No. 3, pp. 360-363, March, 2018

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vodolazhsky, D.I., Kutilin, D.S., Mogushkova, K.A. et al. Specific Features of Transcription Activity of Cancer-Testis Antigens in Patients with Metastatic and Non-Metastatic Breast Cancer. Bull Exp Biol Med 165, 382–385 (2018). https://doi.org/10.1007/s10517-018-4175-x

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-018-4175-x

Key Words

Navigation